Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical hold
Pharma
Astellas, Otsuka, Samsung Biologics—Fierce Pharma Asia
Astellas' CLDN18.2 drug cleared the FDA. Otsuka reported positive readout in IgAN. Samsung Bio signed its largest contract to date. Plus more.
Angus Liu
Oct 25, 2024 8:43am
BMS, China reimbursement update, CAR-T hold—Fierce Pharma Asia
Dec 15, 2023 5:15am
ADC Therapeutics scraps Zynlonta study after FDA partial hold
Jul 21, 2023 11:13am
Astellas, J&J, Sun and more—Fierce Pharma Asia
May 5, 2023 8:55am
'The Top Line': Sarepta's DMD trial, Illumina's Grail quest
Sep 9, 2022 6:00am
FDA slaps clinical hold on Pharvaris' HAE med
Aug 22, 2022 9:58am